USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: VALVEXCHANGE, INC.
Address: c/o Ivan Vesely
Greenwood Village, CO 80111-
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $299,218.00 1
SBIR Phase II $2,693,080.00 2
STTR Phase I $247,873.00 1

Award List:

Exchangeable Heart Valve for Tissue Engineering Applications

Award Year / Program / Phase: 2007 / STTR / Phase I
Agency: HHS
Research Institution: CHILDREN'S HOSPITAL LOS ANGELES
Principal Investigator: Ivan Vesely
Award Amount: $247,873.00
RI Contact: N/A
Abstract:
DESCRIPTION (provided by applicant): Each year, 70,000 patients in the United States need to have their diseased heart valves replaced. These patients can receive either bioprostheses made from animal tissues, or mechanical valves made from synthetic mater ials. Bioprostheses have few complications… More

Anti-fibrotic Coatings for Rapidly Exchangeable Bioprosthetic Heart Valve

Award Year / Program / Phase: 2008 / SBIR / Phase II
Agency: HHS
Principal Investigator:
Award Amount: $1,616,038.00
Abstract:
DESCRIPTION (provided by applicant): Each year, over 100,000 patients in the United States need to have their diseased heart valves replaced with artificial devices. Although bioprostheses, valves made from animal tissues, are considered ideal for most pat ients, they wear out in about 15 years.… More

Beating-Heart Surgery for Heart Valve Replacement

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ivan Vesely
Award Amount: $299,218.00
Abstract:
DESCRIPTION (provided by applicant): Each year, over 115,000 patients in the US need to have their diseased heart valves replaced with artificial devices. Although bioprosthetic valves are considered ideal, they wear out in about 15 years and are thus used primarily in the elderly who are not… More

Beating-Heart Surgery for Heart Valve Replacement

Award Year / Program / Phase: 2012 / SBIR / Phase II
Agency: HHS
Principal Investigator: Ivan Vesely – 303-748-4857
Award Amount: $1,077,042.00
Abstract:
Each year, over 115,000 patients in the US need to have their diseased heart valves replaced with artificial devices. Although bioprosthetic valves are considered ideal, they wear out in about 15 years and are thus used primarily in the elderly who are notexpected to outlive the valve. Younger… More